Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Previous studies have shown that health-related quality of life (HRQL) predicts survival in patients infected with human immunodeficiency virus (HIV). However, these studies predated the highly active antiretroviral therapy (HAART) era, included only a few patients receiving HAART, or had a limited duration of follow-up. This study investigates whether HRQL predicts survival among HIV-infected patients receiving HAART.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Infect Dis

Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publisher: University of Chicago Press

ISSN (Electronic): 1537-6591

ISSN (Print): 1058-4838

Publication date (Electronic): Jan 15 2010

Volume: 50

Issue: 2

Affiliations

[1 ] Department of Medical Psychology, Tropical Medicine and AIDS, Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands. Marion.deboer@amc.uva.nl

Article

DOI: 10.1086/649216

PubMed ID: 20014949

SO-VID: c493e1d6-e34a-4d2f-9c42-e8b8c83d11e5

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by

- Version 1